Children's Hospital Los Angeles, 4650 Sunset Blvd Mailstop 60, Los Angeles, CA 90027, USA.
Curr Rheumatol Rep. 2013 Apr;15(4):322. doi: 10.1007/s11926-013-0322-6.
Progress in the diagnosis and management of pediatric rheumatic disease has improved complications from underlying disease and the survival of children. However, as a consequence, infection has now become one of the leading causes of morbidity and mortality. Differentiating between infections and disease flares in children with rheumatic conditions can often pose diagnostic quandaries. Children with rheumatic diseases are at risk of infection, not only because of the use of immune-modulating medications but also because of underlying immune dysfunction associated with their disease. Although bacterial infections are the most common, any organism can potentially be a causative agent and, at times, more invasive measures of diagnosis, for example bronchoscopy and tissue biopsies may be necessary. Maintaining a high index of suspicion of infection with prompt diagnosis and treatment are important to further improve patient outcomes.
儿科风湿性疾病的诊断和治疗进展改善了基础疾病的并发症和儿童的存活率。然而,因此,感染现在已成为发病率和死亡率的主要原因之一。区分患有风湿性疾病的儿童的感染和疾病发作常常会带来诊断难题。患有风湿性疾病的儿童面临感染风险,不仅是因为使用免疫调节药物,还因为与疾病相关的潜在免疫功能障碍。虽然细菌感染最为常见,但任何病原体都可能成为致病因子,有时需要更具侵袭性的诊断措施,例如支气管镜检查和组织活检。保持对感染的高度怀疑,并及时诊断和治疗,对于进一步改善患者的预后非常重要。